Atara Biotherapeutics earnings were -$133.2M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest ATRA earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$21.9M, up 15% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, ATRA reported annual earnings of -$276.1M, with 20.9% growth. The next ATRA earnings date is Mar 26, 2025.
Atara Biotherapeutics Earnings Reports & History FAQ
What were Atara Biotherapeutics's earnings last quarter?
On ATRA's earnings call on Invalid Date, Atara Biotherapeutics (NASDAQ: ATRA) reported Q3 2024 earnings per share (EPS) of -$2.93, up 82.13% year over year. Total ATRA earnings for the quarter were -$21.91 million. In the same quarter last year, Atara Biotherapeutics's earnings per share (EPS) was -$16.40.
The next ATRA earnings call is Invalid Date. Add ATRA to your watchlist to be reminded of Atara Biotherapeutics's next earnings date.
What was ATRA's earnings growth in the past year?
As of Atara Biotherapeutics's earnings date in Invalid Date, Atara Biotherapeutics's earnings has grown year over year. ATRA earnings in the past year totalled -$133.16 million.
Is Atara Biotherapeutics profitable or losing money?
As of the last Atara Biotherapeutics earnings report, Atara Biotherapeutics is currently losing money. Atara Biotherapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$133.16 million, a 54.12% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.